- Under Thailand's first National Biotechnology Policy Framework (2004 to 2009), 90 new companies were formed, bringing the
number of biotech companies to an estimated total of 170.
- Thailand has succeeded in producing the world's first commercial biosensor for avian influenza. Currently, it is in the process
of producing its first indigenous drug to treat malaria. If successful, it will be a breakthrough development that puts Thailand
on the world map.
- Thailand is regarded as a prime "pharmerging market" due to the potential of its biotech sector. The large population and
academic/healthcare infrastructure make the country an ideal provider of clinical trials.
—Jane Wan is a freelance writer based in Singapore.